[{"symbol": "IRTC", "price": 167.16, "beta": 1.123, "volAvg": 529585, "mktCap": 5385744589, "lastDiv": 0, "range": "92.52-212", "changes": -4.88, "companyName": "iRhythm Technologies, Inc.", "currency": "USD", "cik": "0001388658", "isin": "US4500561067", "cusip": "450056106", "exchange": "NASDAQ Global Select", "exchangeShortName": "NASDAQ", "industry": "Medical - Devices", "website": "https://www.irhythmtech.com", "description": "iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.", "ceo": "Quentin S. Blackford", "sector": "Healthcare", "country": "US", "fullTimeEmployees": "2000", "phone": "415 632 5700", "address": "699 8th Street", "city": "San Francisco", "state": "CA", "zip": "94103", "dcfDiff": 268.91891, "dcf": -101.75891028856535, "image": "https://images.financialmodelingprep.com/symbol/IRTC.png", "ipoDate": "2016-10-20", "defaultImage": false, "isEtf": false, "isActivelyTrading": true, "isAdr": false, "isFund": false}]